-
Lawsuits over the way drugmakers have marketed opioids are already putting a dent in companies' reputations. Litigation has forced the release of internal documents that are shifting the narrative.
-
The Pharmaceutical Research and Manufacturers of America, the brand-name drug industry's main trade group, spent liberally to shift the conversation on prices during the last presidential campaign.
-
If the former drug company executive is confirmed by the Senate, he would replace Dr. Tom Price, who resigned in September after a scandal involving government travel on private aircraft.
-
Senators cited ProPublica reporting that found drug companies have been making patients pay for oversize eyedrops and more liquid cancer medications than they need.
-
If you’ve ever put in an eyedrop, some of it has almost certainly spilled onto your eyelid or cheek. The good news is the mess doesn’t necessarily mean...
-
This story was co-published with The New York Times . At a time when the United States is in the grip of an opioid epidemic , many insurers are limiting...
-
Attorney General Mike DeWine filed a lawsuit against five drug companies on Wednesday, May 31. He believes evidence will show that these drug companies…